Jnana Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced that Joanne Kotz, Ph.D., Co- …